TIRIBELLI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 27.113
EU - Europa 11.196
AS - Asia 5.257
SA - Sud America 477
AF - Africa 121
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 31
Totale 44.243
Nazione #
US - Stati Uniti d'America 26.930
PL - Polonia 2.856
UA - Ucraina 1.834
SG - Singapore 1.670
IT - Italia 1.543
SE - Svezia 1.434
CN - Cina 1.263
HK - Hong Kong 1.160
DE - Germania 624
TR - Turchia 593
FI - Finlandia 569
RU - Federazione Russa 487
BR - Brasile 409
IE - Irlanda 397
BG - Bulgaria 383
GB - Regno Unito 295
NL - Olanda 223
CA - Canada 160
FR - Francia 138
IN - India 127
BE - Belgio 87
VN - Vietnam 79
CH - Svizzera 76
SN - Senegal 63
KR - Corea 62
IR - Iran 50
DK - Danimarca 47
AU - Australia 42
JP - Giappone 38
EE - Estonia 33
ID - Indonesia 31
AT - Austria 30
PK - Pakistan 26
CZ - Repubblica Ceca 25
EU - Europa 24
AR - Argentina 20
ES - Italia 19
TW - Taiwan 19
CL - Cile 18
MX - Messico 15
IL - Israele 14
BD - Bangladesh 13
EG - Egitto 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
MA - Marocco 12
IQ - Iraq 11
PT - Portogallo 10
GR - Grecia 9
PH - Filippine 9
ZA - Sudafrica 9
UZ - Uzbekistan 8
A2 - ???statistics.table.value.countryCode.A2??? 7
EC - Ecuador 7
HR - Croazia 7
KG - Kirghizistan 7
LK - Sri Lanka 7
LT - Lituania 7
NO - Norvegia 7
RS - Serbia 7
TH - Thailandia 7
AM - Armenia 6
AZ - Azerbaigian 6
CO - Colombia 6
GE - Georgia 6
JO - Giordania 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
DZ - Algeria 5
HU - Ungheria 5
KE - Kenya 5
PE - Perù 5
SI - Slovenia 5
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MD - Moldavia 4
MY - Malesia 4
NG - Nigeria 4
PS - Palestinian Territory 4
VE - Venezuela 4
AL - Albania 3
GH - Ghana 3
PA - Panama 3
PY - Paraguay 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BO - Bolivia 2
BY - Bielorussia 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
SC - Seychelles 2
TN - Tunisia 2
UY - Uruguay 2
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
Totale 44.231
Città #
Woodbridge 3.267
Fairfield 3.146
Warsaw 2.847
Ann Arbor 2.730
Houston 2.511
Chandler 2.170
Ashburn 1.746
Jacksonville 1.645
Wilmington 1.552
Seattle 1.341
Hong Kong 1.142
Cambridge 1.056
Singapore 770
Princeton 703
Boardman 596
Izmir 512
Trieste 510
Dublin 386
Sofia 382
Columbus 346
Beijing 288
Moscow 228
San Diego 182
Dearborn 158
Falls Church 158
Santa Clara 145
Des Moines 117
Toronto 114
Milan 100
Brussels 83
Düsseldorf 80
Helsinki 80
Chicago 69
Los Angeles 69
Dakar 63
Shanghai 60
Dong Ket 56
Redwood City 55
Norwalk 53
Washington 53
Kocaeli 51
Bremen 48
Phoenix 47
Buffalo 46
Bern 44
Copenhagen 42
Verona 41
The Dalles 40
Amsterdam 39
Frankfurt am Main 39
Kunming 39
Dallas 38
Guangzhou 36
São Paulo 36
Nanjing 34
Tallinn 33
Jinan 32
Seoul 32
Hefei 31
Krefeld 30
Rome 29
Redmond 28
Munich 25
Nuremberg 25
Indiana 24
Mestre 24
New York 24
Edinburgh 23
Nanchang 21
Tokyo 21
Zurich 21
London 20
Piscataway 20
Venezia 20
Ludhiana 19
Ottawa 19
Tappahannock 19
Vienna 19
Fremont 16
Pune 15
Wuhan 15
Curitiba 14
Hanoi 14
Rio de Janeiro 14
Sacile 14
Atlanta 13
Chandigarh 13
Denver 13
Grafing 13
Hangzhou 13
Shenyang 13
Zhengzhou 13
Fuzhou 12
Lauterbourg 12
Madrid 12
San Francisco 12
Taipei 12
Jakarta 11
Udine 11
Changsha 10
Totale 33.033
Nome #
Bilirubin and inflammation in neurodegenerative and other neurological diseases 525
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 387
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 363
An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 354
The biological effects of bilirubin photoisomers 353
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment 352
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 345
Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis 339
Silencing efficacy prediction: a retrospective study on target mRNA features 337
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 336
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 322
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 319
null 312
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 296
Neuro-inflammatory effects of photodegradative products of bilirubin 289
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat 282
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 270
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 260
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 260
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 235
Heterologous ferredoxin reductase and flavodoxin protect Cos-7 cells from oxidative stress. 224
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat. 210
Anti-transglutaminase antibodies and age. 208
Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. 205
A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. 204
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 200
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 196
A simple index of lipid overaccumulation is a good marker of liver steatosis. 195
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 191
Rapid method for detection of extra (TA) in the promoter of Bilirubin-UDP-Glucuronosyl transferase 1 gene associated with Gilbert Syndrome 190
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents. 188
Predictors of non-alcoholic fatty liver disease in obese children 186
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. 186
Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. 183
Homocysteine in neurology: From endothelium to Neurodegeneration 180
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. 180
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 179
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. 179
Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. 179
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 179
Binding of tritiated bilirubin to albumin and plasma membrane vesicles: a reply 177
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 176
The role of ABC transporters in protecting cells from bilirubin toxicity 175
Liver and adipose tissue interplay through the up-regulation of the Th17 pathway 175
Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups. 174
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 174
Modeling, identification and parameter estimation of bilirubin kinetics in normal, hemolytic and Gilbert's states 173
Biochemical investigations in the management of liver disease 173
Alcohol, liver and genes: an intricate puzzle 172
Alcohol-induced liver disease: From molecular damage to treatment. 170
Liver bromosulphonphthalein transport as a carrier mediated process 170
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 167
The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme 167
Stem cells compartment activation during hepatocarcinogenesis in a HBV-transgenic mouse model 166
The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1 166
Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver. 165
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes 165
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 165
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 163
Alterations in the cell cycle in the cerebellum of hyperbilirubinemic gunn rat: a possible link with apoptosis? 163
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 161
Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome. 160
The pros and the cons for the use of Silybin-rich oral formulations in treatment of liver damage (NAFLD in particular) 160
Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations 160
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 160
Bilistick: A Low Cost Point-of-Care System to Measure Total Plasma Bilirubin 158
Neonatal hyperbilirubinemia 158
Oxidative Stress, Antioxidant Defenses, and the Liver. 157
Role of brain Cytochrome P450 mono-oxygenases in bilirubin oxidation - specific induction and activity. 157
ATP-dependent transport of unconjugated bilirubin by rat liver canalicular plasma membrane vesicles 157
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 156
Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs 155
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 154
A protective effect of breastfeeding on the progression of nonalcoholic fatty liver disease. 154
X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent. 153
The impact of translational research on gastroenterology 152
Bilirubin-induced neurological damage. 151
Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line 151
Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines 150
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 149
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 149
Looking to the horizon: The role of bilirubin in development and prevention of age-related chronic diseases 149
Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase 147
Role and nature of plasma membrane carrier proteins in the hepatic transport of organic anions 147
null 146
Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid composition in rats 146
Body Mass Index is a good predictor of an elevated alanine transaminase level in the general population: Hints from the Dionysos study. 146
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 145
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation. 145
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 145
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. 144
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 144
null 143
Cancer stem cell markers analysis in a HBV-transgenic HCC mouse model 143
Recent insights on hepatic cancer stem cells. 143
The spectrum of liver disease in the general population: Lesson from the Dionysos study. 142
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. 141
Molecular determinants in the transport of a bile acid derived diagnostic agent in tumoral and non-tumoral cell lines of human liver. 141
Disturbances of bilirubin metabolism. 140
Evidence for the existence of a carrier for bromosulphonphthalein in the liver cell plasma membrane. 140
Totale 19.773
Categoria #
all - tutte 137.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.279 0 0 0 0 0 0 0 0 0 409 584 286
2020/20215.778 549 365 424 726 516 600 470 549 238 583 206 552
2021/20224.029 158 305 278 363 112 349 194 179 514 448 282 847
2022/20235.960 513 562 361 838 686 1.143 59 569 756 52 312 109
2023/20243.242 244 219 165 209 357 360 450 645 54 89 227 223
2024/20255.294 100 217 422 693 703 762 615 452 936 394 0 0
Totale 45.329